Exscalate4CoV
Company

Exscalate4CoV

Biotechnology Research 351 employees
Employees
351

Exscalate4CoV Overview

Industry
Biotechnology Research
Employees
351
Founded
2020
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Exscalate4CoV

E4C is a public-private consortium supported by the European Commission’s Horizon 2020 tender for projects to counter the Coronavirus pandemic and improve the management and care of patients. At the core of E4C is Exscalate (EXaSCale smArt pLatform Against paThogEns), at present the most powerful and cost-efficient intelligent supercomputing platform in the world. Exscalate has a "chemical library" of 500 billion molecules and a processing capacity of more than 3 million molecules per second. The E4C consortium, coordinated by Dompé farmaceutici, is composed by 18 members from seven European countries.

Compare Similar Companies to Exscalate4CoV